By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nivalis Therapeutics (Formerly Known As N30 Pharma) 

3122 Sterling Circle

Boulder  Colorado  80301  U.S.A.
Phone: 720-945-7700 Fax: n/a


Key Statistics

Ownership: Public

Web Site: Nivalis
Symbol: NVLS

Company News
Alpine Immune Sciences Completes Merger With Nivalis (NVLS) 7/25/2017 10:27:13 AM
Nivalis (NVLS) Announces Results Of Special Meeting Of Stockholders 7/20/2017 10:59:51 AM
Nivalis (NVLS) Sets Date For Special Meeting Of Stockholders 6/5/2017 2:00:01 PM
Nivalis (NVLS) Reports First Quarter 2017 Financial Results 5/2/2017 6:39:52 AM
Ex-Dendreon (DNDN) CEO Returns to Biotech, Throws a Lifeline to Struggling Nivalis (NVLS) 4/19/2017 5:47:10 AM
Nivalis (NVLS) Announces Results From Phase II Clinical Trial Of Cavosonstat Added To Ivacaftor For Treatment Of Cystic Fibrosis 2/24/2017 7:51:41 AM
Struggling Nivalis (NVLS) Cuts 80% of Staff, Including CEO and CMO 1/13/2017 5:29:29 AM
JPM17: A First: Women in Bio’s Cynthia Smith Tapped for Nivalis (NVLS) Board 1/9/2017 6:26:38 AM
Nivalis (NVLS) Begins Exploring Strategic Alternatives and Streamlining Ops After Clinical Trial Setback 1/4/2017 5:46:28 AM
Nivalis (NVLS) Decimated as Cystic Fibrosis Drug Flops in Mid-Stage Study 11/29/2016 5:37:31 AM